Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. TEM
TEM logo

TEM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TEM News

Tempus Launches PRECISION Challenge to Accelerate Oncology Breakthroughs

20h agoNewsfilter

Tempus AI Unveils New AI-Driven Precision Medicine Data

1d agoseekingalpha

Tempus AI Launches Rapid Clinical Insights Application

20h agoNewsfilter

Tempus AI Unveils Latest Results on Multimodal Foundation Models

1d agoNewsfilter

Tempus AI Receives FDA Approval for Tumor-Only Testing

1d agoNASDAQ.COM

Tempus AI Receives FDA Approval for Tumor-Only Testing

1d agoNewsfilter

Cathie Wood's Investment Strategy Analysis

2d agoFool

Tempus Expands AI Platform to Enhance Cancer Treatment Insights

2d agoNewsfilter

Tempus Hub Upgrade Introduces Advanced AI Co-Pilot

3d agoNewsfilter

Tempus AI to Present 37 Research Abstracts at ASCO 2026

4d agoNewsfilter

Tongcheng Travel Reports 14.4% Revenue Growth in Q1

May 21 2026Yahoo Finance

Tempus AI Launches ArteraAI Prostate Test for Cancer Risk Assessment

May 21 2026stocktwits

Tempus AI Launches ArteraAI Prostate Test for mHSPC

May 21 2026Newsfilter

Surge in Convertible Bond Market Driven by AI Demand

May 20 2026Newsfilter

Tempus Partners with Bristol Myers Squibb to Optimize Clinical Trials

May 14 2026Newsfilter

MindBio Launches AI Voice Detection Technology for Intoxication

May 11 2026Globenewswire